基于香酸的益凝剂血静形状记忆聚合物泡具有对抗药物耐药细菌的抗微生物特性
Changling Du1, David Anthony Fikhman1, Ernest Emmanuel Obeng1
1Department of Biomedical and Chemical Engineering, Syracuse Biomaterials Institute, and BioInspired Syracuse: Institute for Material and Living Systems, Syracuse University, Syracuse, NY 13244, United States.
Acta biomaterialia
|September 29, 2024
概括
新的双酸 (DVA) 泡为创伤性伤口提供了低成本的解决方案. 这些止血既能快速凝血,又能对抗耐药性细菌感染,改善患者的治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 伤口护理技术 伤口护理技术
背景情况:
- 失控出血是创伤死亡的主要原因.
- 创伤伤口容易受到危险的耐药细菌感染.
- 需要具有抗微生物特性,具有成本效益的血液静止剂.
研究的目的:
- 开发新的双酸 (DVA) 形状记忆聚合物 (SMP) 泡.
- 为了增强香酸 (VA) 的加载,并控制其在爆发和持续交付时的释放.
- 为了创建一个具有前凝和抗菌能力的静血.
主要方法:
- 使用双重机制将香酸 (VA) 纳入形状记忆聚合物 (SMP) 泡中.
- 对DVA泡的抗菌和抗菌膜活性对金黄色葡萄球菌和上皮葡萄球菌的评估.
- 在体外和猪肝损伤模型中评估DVA泡的静血性质.
主要成果:
- DVA泡对本地和耐药细菌均表现出显著的抗微生物和抗菌膜作用.
- 泡有效抑制了细菌的生长,并促进了小殖民地变种.
- 实验室研究证实DVA泡诱导了初级和二级血静.
- 一个猪肝损伤模型显示了快速凝血 (<5分钟) 和可行性作为静血包裹.
结论:
- 廉价的DVA SMP泡为控制出血和预防创伤中感染提供了一个有希望的解决方案.
- 这些生物材料提供了具有成本效益的双重作用的静血包裹.
- 通过解决出血和感染问题,DVA泡可以改善创伤患者的短期和长期结果.
相关概念视频
Anionic Chain-Growth Polymerization: Overview
The polymerization process that involves carbanion as an intermediate is called anionic polymerization. It is also a type of addition or chain-growth polymerization. Anionic polymerization gets initiated by a strong nucleophile such as an organolithium or a Grignard reagent. The most commonly used initiator for anionic polymerization is butyl lithium. Monomers involved in anionic polymerization must possess a vinyl group bonded to one or two electron-withdrawing groups. For instance,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


